6:44 am An employee of a Main Street
gas station reported that a person was
sleeping on their picnic table...
5:53 pm Officer Matthew McNeil
arrested a 17 year old male on East Main Street and charged him with
Crosswalk Violation...
12:02 am Between the hours of 9:05 pm
and 12:02 am police received six calls complaining of vehicle's parking
on the side of the road and loud noise from a block party on Lakeshore
Drive...
5:17 pm A caller from Main Street
reported that his neighbor turned around in his driveway and would like
to speak with an officer...
Giving it
Away
August 13,
2007 —Louis Sakim, Sealer of Weights an Measures, checks the accuracy of
the pumps at a gas station on West Main Street this morning. Mr. Sakim
must inspect all of the pumps in town at least once a year, or sooner if
there are complaints. This particular pump was actually outside of the
margin of error. It was giving away too much gas.
"This will have to be calibrated," said Mr. Sakim.
Hopkinton
Company Expands Industry-wide Licensing of Product
Caliper’s Optical Imaging Patent Suite™ Enhances
Drug Discovery Efforts
August 13, 2007 -- Caliper Life Sciences,
Inc. (NASDAQ: CALP) today announced that pharmaceutical giant Novartis
has signed a multi-year license to Caliper’s patented non-invasive
optical imaging methods.
Non-invasive optical imaging, an increasingly critical technology for
drug discovery and development, allows scientists to
visualize, track and quantify biological processes at the molecular
level in living animals with high throughput and relatively low cost.
Caliper, the industry leader in small animal optical imaging solutions,
provides commercial and academic customers with an impressive selection
of in vivo offerings including imaging systems, reagents, applications,
proprietary methods and services that improve drug discovery and
development efforts. This method replaces surgery in tracking the
effects of a proposed new drug on a laboratory animal, such as a mouse.
“This multi-year agreement further validates the
importance and relevance of Caliper’s optical imaging technology and
intellectual property,” said Kevin Hrusovsky (File photo), chief
executive officer, Caliper Life Sciences. “More than 70% of major
pharmaceutical companies, and 60% of major biotech companies, now hold a
license to the Caliper Optical Imaging Patent Suite, and smaller
biotechs are following suit in increasing numbers.” Hrusovsky added,
“Our recent notification of allowance of patent claims for conjugate
fluorescence imaging methods from the U.S. Patent and Trademark Office
has significantly increased the value of Caliper’s intellectual property
estate and complements Caliper’s aggressive investment in conjugate
probe development.”
Caliper’s Xenogen family of IVIS® instrument systems,
reagents, and proprietary methods deliver noninvasive in vivo imaging
along with high sensitivity, ease of use and exceptional data quality.
Caliper has placed over 450 units to date and recently launched the new
Xenogen IVIS Spectrum™ system, the first system to provide
state-of-the-art bioluminescence and fluorescence capability in a single
unit.
"The
News Starts Here!"
Click here to make HopNews your default
homepage! <---works with Internet Explorer.
sleeping on their picnic table...
visualize, track and quantify biological processes at the molecular
level in living animals with high throughput and relatively low cost.
